Citation: Rj. Simonds et al., PREVENTING PNEUMOCYSTIS-CARINII PNEUMONIA IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 44-48
Citation: Pm. Flynn et al., USE OF ABDOMINAL COMPUTED-TOMOGRAPHY FOR IDENTIFYING DISSEMINATED FUNGAL INFECTION IN PEDIATRIC CANCER-PATIENTS, Clinical infectious diseases, 20(4), 1995, pp. 964-970
Citation: Wt. Hughes, RISK ANALYSIS AND ASSET VALUTION - A MONTE-CARLO SIMULATION USING STOCHASTIC RENTS, Journal of real estate finance and economics, 11(2), 1995, pp. 177-187
Citation: Wt. Hughes et Hs. Oz, SUCCESSFUL PREVENTION AND TREATMENT OF BABESIOSIS WITH ATOVAQUONE, The Journal of infectious diseases, 172(4), 1995, pp. 1042-1046
Citation: Sl. Vargas et al., LIMITED PERSISTENCE IN AND SUBSEQUENT ELIMINATION OF PNEUMOCYSTIS-CARINII FROM THE LUNGS AFTER PNEUMOCYSTIS-CARINII PNEUMONIA, The Journal of infectious diseases, 172(2), 1995, pp. 506-510
Citation: Wt. Hughes et al., ADVERSE EVENTS ASSOCIATED WITH TRIMETHOPRIM-SULFAMETHOXAZOLE AND ATOVAQUONE DURING THE TREATMENT OF AIDS-RELATED PNEUMOCYSTIS-CARINII PNEUMONIA, The Journal of infectious diseases, 171(5), 1995, pp. 1295-1301
Citation: Sk. Sanyal et al., SEQUENTIAL-CHANGES IN VITAL SIGNS AND ACID-BASE AND BLOOD-GAS PROFILES IN PNEUMOCYSTIS-CARINII PNEUMONITIS IN CHILDREN WITH CANCER - BASIS FOR A SCORING SYSTEM TO IDENTIFY PATIENTS WHO WILL REQUIRE VENTILATORYSUPPORT, American journal of respiratory and critical care medicine, 149(5), 1994, pp. 1092-1098
Citation: Wt. Hughes, PNEUMOCYSTIS-CARINII - WHAT IS IT AND FROM WHENCE DOES IT COME, The Journal of eukaryotic microbiology, 41(5), 1994, pp. 190000123-190000123
Citation: Wt. Hughes, PNEUMOCYSTIS-CARINII - WHAT IS IT AND FROM WHENCE DOES IT COME, The Journal of eukaryotic microbiology, 41(5), 1994, pp. 190000123-190000123
Citation: Ch. Pui et al., PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA IN CHILDREN WITH CANCER, Journal of clinical oncology, 12(7), 1994, pp. 1522-1522
Authors:
WAKEFIELD AE
FRITSCHER CC
MALIN AS
GWANZURA L
HUGHES WT
MILLER RF
Citation: Ae. Wakefield et al., GENETIC DIVERSITY IN HUMAN-DERIVED PNEUMOCYSTIS-CARINII ISOLATES FROM4 GEOGRAPHICAL LOCATIONS SHOWN BY ANALYSIS OF MITOCHONDRIAL RIBOSOMAL-RNA GENE-SEQUENCES, Journal of clinical microbiology, 32(12), 1994, pp. 2959-2961
Citation: Jl. Shenep et al., DECREASED COUNTS OF BLOOD NEUTROPHILS, MONOCYTES, AND PLATELETS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AND YOUNG-ADULTS TREATED WITH DIETHYLDITHIOCARBAMATE, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1644-1646
Citation: Wt. Hughes et al., RELATIVE POTENCY OF 10 DRUGS WITH ANTIPNEUMOCYSTIS CARINII ACTIVITY IN AN ANIMAL-MODEL, The Journal of infectious diseases, 170(4), 1994, pp. 906-911
Authors:
HUGHES WT
JACOBUS DP
CANFIELD C
KILLMAR J
Citation: Wt. Hughes et al., ANTI-PNEUMOCYSTIS-CARINII ACTIVITY OF PS-15, A NEW BIGUANIDE FOLATE ANTAGONIST, Antimicrobial agents and chemotherapy, 37(7), 1993, pp. 1417-1419
Citation: Sl. Vargas et al., AZITHROMYCIN FOR TREATMENT OF SEVERE CRYPTOSPORIDIUM DIARRHEA IN 2 CHILDREN WITH CANCER, The Journal of pediatrics, 123(1), 1993, pp. 154-156